HDT BIO CORP
Federal contract awards won by HDT BIO CORP (UEI Z33DCMWXZBK7), 2019–2023 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
4
awards
0
expiring in 12 months
1
agency
Teaming snapshot
teams under 1 prime.
From subcontract reports primes file with USAspending/FSRS.
Category award history
5 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: TDA RESEARCH, INC. took Department of Defense 541715 work from HDT BIO CORP (Apr 13, 2026).
Agencies buying from HDT BIO CORP
What HDT BIO CORP has provided
Awards
HDT BIO CORP - AOI #21 VACCINE ON DEMAND: R&D USE OF LION-REPRNA IN RAPID RESPONSE VACCINE DEVELOPMENT
Department of Health and Human Services · $749,000 · Sep 22, 2023
ADAPTABLE RNA-BASED ANTIBODY PLATFORM FOR PROTECTION AGAINST CONTEMPORARY/EMERGING HUMAN ENTEROVIRUSES
Department of Health and Human Services · $1,499,422 · Jul 1, 2022
COVID-19. TO DEVELOP AND PROGRESS HDT-301, A REPLICON RNA ENCODING SARS-COV-2 SPIKE PROTEIN BOUND TO LIPID INORGANIC NANOPARTICLE (LION) FORMULATION TO PROTECT AGAINST COVID-19, THROUGH A PHASE I CLINICAL TRIAL.
Department of Health and Human Services · $10,970,058 · Sep 1, 2020
RATIONAL DEVELOPMENT OF A COMBINATION NANOPARTICLE ADJUVANT FOR INFLUENZA.
Department of Health and Human Services · $599,629 · Sep 1, 2019